Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Fleming

Showing results (51-60 of 81) with videos related to

Pageof 9
Sort By:
Fertility and Sterility|May 25, 2015
Antimüllerian hormone levels and antral follicle count as prognostic indicators in a personalized prediction model of live birthScott M Nelson, Richard Fleming, Marco Gaudoin, et al.
Fertility and Sterility|August 28, 2012
Interpreting human follicular recruitment and antimüllerian hormone concentrations throughout lifeRichard Fleming, Tom W Kelsey, Richard A Anderson, et al.
Fertility and Sterility|February 12, 2013
Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patientsJoan-Carles Arce, Antonio La Marca, Bjarke Mirner Klein, et al.
Australasian Journal on Ageing|September 7, 2012
Validation of the Environmental Audit Tool in both purpose-built and non-purpose-built dementia care settingsRonald Smith, Richard Fleming, Lynn Chenoweth, et al.
Bioinformation|December 30, 2025
Retrospective cohort study on long-term anticoagulation therapy for bleeding complications among atrial fibrillation patientsMegha Joy, Bethamcherla Bala Chandrudu, Mohamed Thoufeek Hussain Amjat Ibrahim, et al.
Fertility and Sterility|January 18, 2005
Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatmentRichard Fleming, Lyndal Harborne, David T MacLaughlin, et al.
Human Reproduction (Oxford, England)|July 23, 2013
Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre studyStamatina Iliodromiti, Christophe Blockeel, Kelton P Tremellen, et al.
Dementia (London, England)|August 14, 2019
Creating a dementia enabling university using a Knowledge Translation approach: Innovative practiceLyn Phillipson, Richard Fleming, Kate Swaffer, et al.
Human Fertility (Cambridge, England)|January 16, 2023
FSH administration at 12-hour intervals for the first 2 days, combined with mandatory GnRH-agonist trigger and blastocyst vitrification in women (<80Kg) with high AMH levels, results in higher cumulative live birth rates and is saferRichard Fleming, Mariano Mascarenhas, Frances Roebuck, et al.
The Cochrane Database of Systematic Reviews|March 7, 2022
Physical environmental designs in residential care to improve quality of life of older peopleStephanie L Harrison, Suzanne M Dyer, Kate E Laver, et al.
Pageof 9

Showing results (51-60 of 81) with videos related to

Sort By:
Pageof 9
Fertility and Sterility|May 25, 2015
Antimüllerian hormone levels and antral follicle count as prognostic indicators in a personalized prediction model of live birthScott M Nelson, Richard Fleming, Marco Gaudoin, et al.
Fertility and Sterility|August 28, 2012
Interpreting human follicular recruitment and antimüllerian hormone concentrations throughout lifeRichard Fleming, Tom W Kelsey, Richard A Anderson, et al.
Fertility and Sterility|February 12, 2013
Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patientsJoan-Carles Arce, Antonio La Marca, Bjarke Mirner Klein, et al.
Australasian Journal on Ageing|September 7, 2012
Validation of the Environmental Audit Tool in both purpose-built and non-purpose-built dementia care settingsRonald Smith, Richard Fleming, Lynn Chenoweth, et al.
Bioinformation|December 30, 2025
Retrospective cohort study on long-term anticoagulation therapy for bleeding complications among atrial fibrillation patientsMegha Joy, Bethamcherla Bala Chandrudu, Mohamed Thoufeek Hussain Amjat Ibrahim, et al.
Fertility and Sterility|January 18, 2005
Metformin reduces serum mullerian-inhibiting substance levels in women with polycystic ovary syndrome after protracted treatmentRichard Fleming, Lyndal Harborne, David T MacLaughlin, et al.
Human Reproduction (Oxford, England)|July 23, 2013
Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre studyStamatina Iliodromiti, Christophe Blockeel, Kelton P Tremellen, et al.
Dementia (London, England)|August 14, 2019
Creating a dementia enabling university using a Knowledge Translation approach: Innovative practiceLyn Phillipson, Richard Fleming, Kate Swaffer, et al.
Human Fertility (Cambridge, England)|January 16, 2023
FSH administration at 12-hour intervals for the first 2 days, combined with mandatory GnRH-agonist trigger and blastocyst vitrification in women (<80Kg) with high AMH levels, results in higher cumulative live birth rates and is saferRichard Fleming, Mariano Mascarenhas, Frances Roebuck, et al.
The Cochrane Database of Systematic Reviews|March 7, 2022
Physical environmental designs in residential care to improve quality of life of older peopleStephanie L Harrison, Suzanne M Dyer, Kate E Laver, et al.
Pageof 9